Your browser doesn't support javascript.
loading
Activation-inducible CAR expression enables precise control over engineered CAR T cell function.
Fraessle, Simon P; Tschulik, Claudia; Effenberger, Manuel; Cletiu, Vlad; Gerget, Maria; Schober, Kilian; Busch, Dirk H; Germeroth, Lothar; Stemberger, Christian; Poltorak, Mateusz P.
Afiliación
  • Fraessle SP; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Tschulik C; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Effenberger M; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany. manuel.effenberger@bms.com.
  • Cletiu V; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Gerget M; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Schober K; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
  • Busch DH; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
  • Germeroth L; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Stemberger C; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Poltorak MP; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
Commun Biol ; 6(1): 604, 2023 06 05.
Article en En | MEDLINE | ID: mdl-37277433

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Alemania